CTAGE4 Inhibitors
CTAGE4 inhibitors are a class of chemicals that can potentially inhibit the function of the CTAGE4 protein. CTAGE4, also known as Cutaneous T-cell lymphoma-associated antigen 4, is a protein involved in intracellular trafficking and vesicular transport processes. The inhibitors of CTAGE4 can act through various mechanisms to disrupt its function. Brefeldin A, for example, inhibits CTAGE4 by disrupting the formation of COPI-coated vesicles, which are essential for intracellular trafficking. Monensin A and Nystatin, Streptomyces noursei, on the other hand, disrupt membrane integrity and lipid organization, affecting the processes mediated by CTAGE4.
Other inhibitors like Nocodazole and Latrunculin B, Latrunculia magnifica disrupt microtubule dynamics and actin polymerization, respectively, which are involved in intracellular transport processes mediated by CTAGE4. Wortmannin and Dynamin Inhibitor I, Dynasore inhibit PI3K and dynamin, respectively, which are signaling enzymes involved in intracellular trafficking and endocytosis. Chlorpromazine and Pitstop 2 disrupt clathrin-mediated endocytosis, an important process for CTAGE4-mediated intracellular trafficking. N-ethylmaleimide modifies cysteine residues and disrupts protein-protein interactions essential for CTAGE4 function. Methyl-β-cyclodextrin disrupts lipid rafts, which play a role in intracellular trafficking processes. Overall, CTAGE4 inhibitors are a diverse group of chemicals that can potentially inhibit the function of CTAGE4 by targeting various cellular processes involved in intracellular trafficking and vesicular transport. These inhibitors can disrupt the formation of COPI-coated vesicles, microtubule dynamics, actin polymerization, membrane integrity, lipid organization, and protein-protein interactions. By targeting these processes, CTAGE4 inhibitors have the potential to interfere with the normal function of CTAGE4 and may be useful tools for studying its role in cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A is a fungal metabolite that can potentially inhibit CTAGE4 by disrupting the formation of COPI-coated vesicles, which are involved in intracellular trafficking. This can lead to the inhibition of CTAGE4-mediated processes. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin A is an ionophore antibiotic that can potentially inhibit CTAGE4 by disrupting ion transport and membrane potential, which are essential for CTAGE4-mediated processes. This can lead to the inhibition of CTAGE4 function. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole is a microtubule-depolymerizing agent that can potentially inhibit CTAGE4 by disrupting microtubule dynamics, which are involved in intracellular transport. This can lead to the inhibition of CTAGE4-mediated processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a fungal metabolite that can potentially inhibit CTAGE4 by inhibiting phosphoinositide 3-kinase (PI3K), a signaling enzyme involved in intracellular trafficking. This can lead to the inhibition of CTAGE4 function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynamin Inhibitor I, Dynasore is a small molecule inhibitor that can potentially inhibit CTAGE4 by inhibiting dynamin, a GTPase involved in endocytosis. This can lead to the inhibition of CTAGE4-mediated processes. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is an antipsychotic drug that can potentially inhibit CTAGE4 by disrupting clathrin-mediated endocytosis, which is involved in intracellular trafficking. This can lead to the inhibition of CTAGE4 function. | ||||||
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $69.00 $214.00 $796.00 $1918.00 | 19 | |
N-ethylmaleimide is a thiol-reactive compound that can potentially inhibit CTAGE4 by modifying cysteine residues and disrupting protein-protein interactions essential for CTAGE4-mediated processes. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Methyl-β-cyclodextrin is a cyclic oligosaccharide that can potentially inhibit CTAGE4 by disrupting lipid rafts, which are involved in intracellular trafficking. This can lead to the inhibition of CTAGE4 function. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D is a fungal metabolite that can potentially inhibit CTAGE4 by disrupting actin polymerization, which is involved in intracellular transport. This can lead to the inhibition of CTAGE4-mediated processes. | ||||||
Nystatin | 1400-61-9 | sc-212431 sc-212431A sc-212431B sc-212431C | 5 MU 25 MU 250 MU 5000 MU | $51.00 $129.00 $251.00 $3570.00 | 7 | |
Nystatin, Streptomyces noursei is an antifungal compound that can potentially inhibit CTAGE4 by disrupting membrane integrity and lipid organization, which are essential for CTAGE4-mediated processes. This can lead to the inhibition of CTAGE4 function. | ||||||